ℹ️
🇬🇧
Search
Search for people relevant for "Retrospect"
Retrospect
Person
Class
Person
Publication
Programmes
MUDr. Martin Šimkovič Ph.D.
Academic staff at Faculty of Medicine in Hradec Králové
90 publications
Publications
publication
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: The GO-CLLEAR Study by the Czech CLL Study Group
2020 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
publication
Frontline treatment with the combination obinutuzumab +/- chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group
2020 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders
2019 |
Faculty of Medicine in Hradec Králové
publication
Is percutaneous computed tomography-guided biopsy sufficient to establish indolent lymphoma transformation?
2019 |
Faculty of Medicine in Hradec Králové
publication
Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia
2016 |
Faculty of Medicine in Hradec Králové
publication
Venous thromboembolism in patients with chronic lymphocytic leukemia
2015 |
Faculty of Medicine in Hradec Králové
publication
Rituximab infusion-related toxicity in patients with chronic lymphocytic leukemia
2015 |
Faculty of Medicine in Hradec Králové
publication
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab
2013 |
Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Efficacy of rituximab in primary immune thrombocytopenia: An analysis of adult pretreated patients from everyday hematological practice
2012 |
Faculty of Medicine in Hradec Králové, Central Library of Charles University, Third Faculty of Medicine
publication
Idelalisib plus rituximab versus ibrutinib in the treatment of relapsed/refractory chronic lymphocytic leukaemia: A real-world analysis from the Chronic Lymphocytic Leukemia Patients Registry (CLLEAR)
2023 |
Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, First Faculty of Medicine
Load more publications (80)
Loading network view...